Metropolitan Life Insurance CO Beyond Spring Inc. Transaction History

Metropolitan Life Insurance CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Jun 21, 2023	BUY	$9.26 - $31.31 $57,254 - $193,589	6,183 New	6,183 $97.4 Million
Q3 2020 Jun 26, 2023	BUY	$9.99 - $16.13 $50,978 - $82,311	5,103 New	5,103 $67.9 Million
Q2 2020 Jun 26, 2023	BUY	$11.21 - $18.15 $52,339 - $84,742	4,669 New	4,669 $70.4 Million
Q1 2020 Jul 12, 2023	BUY	$9.68 - $18.47 $44,905 - $85,682	4,639 New	4,639 $59.4 Million

5.77M

53.2K

2.5K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $91.5M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.